| 9.2 |
27.6 |
GO:0046959 |
habituation(GO:0046959) |
| 6.8 |
20.5 |
GO:0032513 |
negative regulation of protein phosphatase type 2B activity(GO:0032513) |
| 6.6 |
105.5 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 6.3 |
18.8 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 4.8 |
14.3 |
GO:1901731 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
| 4.6 |
18.2 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 4.5 |
13.6 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 4.5 |
17.9 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 3.9 |
15.7 |
GO:1901204 |
positive regulation of guanylate cyclase activity(GO:0031284) regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) |
| 3.8 |
18.8 |
GO:0021636 |
trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
| 3.6 |
14.3 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 3.4 |
13.6 |
GO:0090238 |
positive regulation of arachidonic acid secretion(GO:0090238) |
| 3.3 |
16.7 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 3.2 |
45.0 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 3.0 |
8.9 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 2.9 |
5.8 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 2.9 |
5.7 |
GO:0070885 |
negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 2.8 |
14.1 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 2.7 |
24.5 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 2.7 |
16.3 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 2.7 |
8.1 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
| 2.7 |
18.9 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 2.5 |
7.5 |
GO:0097401 |
synaptic vesicle lumen acidification(GO:0097401) |
| 2.5 |
7.5 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 2.5 |
12.3 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 2.4 |
7.2 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 2.4 |
9.6 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 2.4 |
7.1 |
GO:0043379 |
memory T cell differentiation(GO:0043379) |
| 2.3 |
11.6 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 2.3 |
7.0 |
GO:0070428 |
regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
| 2.3 |
6.9 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 2.3 |
9.2 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 2.3 |
11.5 |
GO:0060178 |
regulation of exocyst localization(GO:0060178) |
| 2.3 |
6.8 |
GO:0071895 |
odontoblast differentiation(GO:0071895) |
| 2.3 |
6.8 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 2.1 |
8.6 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 2.1 |
6.3 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 2.0 |
6.0 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 2.0 |
8.0 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 2.0 |
13.8 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 2.0 |
7.9 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 2.0 |
15.7 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 1.9 |
1.9 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 1.9 |
7.8 |
GO:0031622 |
positive regulation of fever generation(GO:0031622) |
| 1.9 |
5.8 |
GO:0021577 |
hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 1.9 |
1.9 |
GO:0055005 |
ventricular cardiac myofibril assembly(GO:0055005) |
| 1.8 |
7.1 |
GO:0097343 |
ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 1.7 |
6.9 |
GO:0046709 |
IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 1.7 |
13.7 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 1.7 |
5.1 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 1.7 |
6.8 |
GO:0030397 |
membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 1.7 |
5.1 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 1.7 |
34.0 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 1.7 |
5.0 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 1.6 |
8.2 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 1.6 |
16.2 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 1.6 |
4.9 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 1.6 |
9.7 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 1.6 |
12.9 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 1.6 |
15.9 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 1.6 |
7.9 |
GO:1903423 |
positive regulation of synaptic vesicle recycling(GO:1903423) |
| 1.6 |
12.6 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 1.6 |
4.7 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 1.6 |
9.4 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 1.6 |
4.7 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 1.6 |
4.7 |
GO:0070649 |
formin-nucleated actin cable assembly(GO:0070649) |
| 1.6 |
21.7 |
GO:0021540 |
corpus callosum morphogenesis(GO:0021540) |
| 1.5 |
6.2 |
GO:0071680 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 1.5 |
32.3 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 1.5 |
4.5 |
GO:1902277 |
negative regulation of pancreatic amylase secretion(GO:1902277) |
| 1.5 |
7.5 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 1.5 |
6.0 |
GO:0090273 |
regulation of somatostatin secretion(GO:0090273) |
| 1.5 |
8.9 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 1.5 |
8.9 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 1.5 |
20.6 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 1.4 |
5.8 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 1.4 |
20.1 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 1.4 |
5.7 |
GO:0044861 |
protein localization to plasma membrane raft(GO:0044860) protein transport into plasma membrane raft(GO:0044861) |
| 1.4 |
14.2 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 1.4 |
9.9 |
GO:0032276 |
regulation of gonadotropin secretion(GO:0032276) |
| 1.4 |
2.8 |
GO:2000015 |
regulation of determination of dorsal identity(GO:2000015) |
| 1.4 |
8.4 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 1.4 |
8.2 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 1.3 |
1.3 |
GO:1903181 |
regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 1.3 |
9.3 |
GO:2000809 |
positive regulation of synaptic vesicle clustering(GO:2000809) |
| 1.3 |
7.8 |
GO:0021814 |
cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
| 1.3 |
15.6 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 1.3 |
1.3 |
GO:0003273 |
cell migration involved in endocardial cushion formation(GO:0003273) |
| 1.2 |
1.2 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 1.2 |
2.5 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 1.2 |
6.1 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 1.2 |
7.2 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 1.2 |
27.2 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 1.2 |
8.3 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 1.2 |
5.9 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 1.2 |
3.5 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 1.2 |
10.6 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 1.2 |
3.5 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 1.2 |
9.3 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 1.2 |
3.5 |
GO:0043416 |
regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 1.1 |
3.4 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 1.1 |
5.6 |
GO:0046113 |
nucleobase catabolic process(GO:0046113) |
| 1.1 |
3.4 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 1.1 |
3.4 |
GO:1990314 |
pyrimidine-containing compound transmembrane transport(GO:0072531) cellular response to insulin-like growth factor stimulus(GO:1990314) |
| 1.1 |
5.6 |
GO:0014832 |
urinary bladder smooth muscle contraction(GO:0014832) |
| 1.1 |
2.2 |
GO:0050748 |
negative regulation of lipoprotein metabolic process(GO:0050748) |
| 1.1 |
5.4 |
GO:0042518 |
negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
| 1.1 |
3.2 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 1.1 |
3.2 |
GO:0009838 |
abscission(GO:0009838) positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 1.1 |
17.2 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 1.1 |
4.3 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 1.1 |
2.1 |
GO:1903243 |
negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 1.1 |
4.2 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 1.1 |
3.2 |
GO:0002035 |
brain renin-angiotensin system(GO:0002035) |
| 1.0 |
3.1 |
GO:0021764 |
amygdala development(GO:0021764) |
| 1.0 |
3.1 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 1.0 |
3.1 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 1.0 |
3.1 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 1.0 |
14.3 |
GO:1900745 |
positive regulation of p38MAPK cascade(GO:1900745) |
| 1.0 |
6.1 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 1.0 |
3.1 |
GO:2000834 |
androgen secretion(GO:0035935) testosterone secretion(GO:0035936) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 1.0 |
5.1 |
GO:0030242 |
pexophagy(GO:0030242) |
| 1.0 |
3.0 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 1.0 |
6.9 |
GO:0006361 |
transcription initiation from RNA polymerase I promoter(GO:0006361) |
| 1.0 |
2.9 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 1.0 |
11.7 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 1.0 |
2.0 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 1.0 |
6.8 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 1.0 |
3.9 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 1.0 |
4.8 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 1.0 |
2.9 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 1.0 |
5.8 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 1.0 |
2.9 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 1.0 |
9.6 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 1.0 |
2.9 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 1.0 |
4.8 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.9 |
3.8 |
GO:0007066 |
female meiosis sister chromatid cohesion(GO:0007066) |
| 0.9 |
5.7 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.9 |
3.7 |
GO:0086011 |
membrane repolarization during action potential(GO:0086011) regulation of membrane repolarization during action potential(GO:0098903) |
| 0.9 |
6.5 |
GO:0021681 |
cerebellar granular layer development(GO:0021681) |
| 0.9 |
25.1 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 0.9 |
3.7 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.9 |
5.5 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.9 |
1.8 |
GO:0030205 |
dermatan sulfate metabolic process(GO:0030205) |
| 0.9 |
10.0 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.9 |
7.3 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.9 |
2.7 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.9 |
5.4 |
GO:0046103 |
ADP biosynthetic process(GO:0006172) inosine biosynthetic process(GO:0046103) |
| 0.9 |
3.6 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.9 |
20.3 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.9 |
0.9 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.9 |
0.9 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 0.9 |
4.3 |
GO:0045762 |
positive regulation of adenylate cyclase activity(GO:0045762) |
| 0.9 |
1.7 |
GO:1904192 |
cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
| 0.8 |
3.4 |
GO:0071476 |
cellular hypotonic response(GO:0071476) |
| 0.8 |
13.5 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.8 |
9.2 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.8 |
2.5 |
GO:0001803 |
antibody-dependent cellular cytotoxicity(GO:0001788) type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
| 0.8 |
1.7 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) negative regulation of hair follicle development(GO:0051799) |
| 0.8 |
7.4 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.8 |
3.3 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.8 |
2.5 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.8 |
4.9 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 0.8 |
2.5 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) |
| 0.8 |
55.8 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.8 |
4.0 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.8 |
9.5 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.8 |
7.1 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.8 |
2.4 |
GO:1900242 |
regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.8 |
5.5 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.8 |
33.4 |
GO:0046627 |
negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.8 |
3.1 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.8 |
1.5 |
GO:0071672 |
negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
| 0.8 |
15.3 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.8 |
3.0 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.8 |
6.8 |
GO:0008054 |
negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
| 0.8 |
2.3 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.7 |
22.5 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.7 |
6.7 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
| 0.7 |
12.6 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.7 |
3.0 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.7 |
21.1 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.7 |
18.1 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.7 |
2.9 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.7 |
2.8 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.7 |
9.2 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.7 |
21.1 |
GO:0009268 |
response to pH(GO:0009268) |
| 0.7 |
9.1 |
GO:0043482 |
pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) |
| 0.7 |
2.1 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.7 |
2.1 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.7 |
6.1 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.7 |
5.4 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.7 |
1.3 |
GO:0045448 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.7 |
4.0 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.7 |
6.0 |
GO:0015838 |
amino-acid betaine transport(GO:0015838) |
| 0.7 |
1.3 |
GO:2000110 |
negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.7 |
1.3 |
GO:0090202 |
transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.7 |
2.7 |
GO:2001012 |
mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.7 |
4.0 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.7 |
2.0 |
GO:0002692 |
negative regulation of cellular extravasation(GO:0002692) negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.7 |
2.6 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.7 |
11.2 |
GO:0006182 |
cGMP biosynthetic process(GO:0006182) |
| 0.7 |
2.0 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.7 |
3.9 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.7 |
2.0 |
GO:0009182 |
purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 0.7 |
3.3 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.7 |
5.9 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.7 |
5.9 |
GO:0035280 |
miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
| 0.6 |
21.3 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 0.6 |
2.6 |
GO:0090170 |
regulation of Golgi inheritance(GO:0090170) |
| 0.6 |
3.8 |
GO:2001023 |
regulation of response to drug(GO:2001023) |
| 0.6 |
7.0 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.6 |
8.3 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.6 |
3.8 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.6 |
7.0 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.6 |
2.5 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.6 |
5.0 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.6 |
1.9 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.6 |
0.6 |
GO:0010748 |
negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.6 |
16.7 |
GO:2001240 |
negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
| 0.6 |
1.2 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.6 |
0.6 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.6 |
4.8 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
| 0.6 |
3.0 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.6 |
6.6 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.6 |
7.1 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.6 |
2.4 |
GO:0042891 |
antibiotic transport(GO:0042891) |
| 0.6 |
20.1 |
GO:0047496 |
vesicle transport along microtubule(GO:0047496) |
| 0.6 |
2.4 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.6 |
2.4 |
GO:0015788 |
UDP-N-acetylglucosamine transport(GO:0015788) |
| 0.6 |
2.9 |
GO:0035898 |
parathyroid hormone secretion(GO:0035898) |
| 0.6 |
3.5 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
| 0.6 |
1.7 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.6 |
3.5 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.6 |
4.6 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.6 |
6.8 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.6 |
2.2 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.6 |
4.5 |
GO:0032096 |
negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.6 |
2.2 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.6 |
1.7 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.6 |
9.5 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.6 |
1.7 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.6 |
3.9 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.6 |
3.9 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.5 |
1.1 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 0.5 |
5.5 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.5 |
2.7 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.5 |
1.6 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.5 |
1.6 |
GO:0034145 |
positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.5 |
2.2 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.5 |
1.1 |
GO:0002578 |
negative regulation of antigen processing and presentation(GO:0002578) |
| 0.5 |
1.6 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.5 |
1.1 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.5 |
2.1 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.5 |
3.7 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.5 |
1.6 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.5 |
1.5 |
GO:0010511 |
regulation of phosphatidylinositol biosynthetic process(GO:0010511) negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.5 |
10.3 |
GO:0071108 |
protein K63-linked deubiquitination(GO:0070536) protein K48-linked deubiquitination(GO:0071108) |
| 0.5 |
3.6 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.5 |
4.1 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.5 |
3.1 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.5 |
17.8 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.5 |
1.5 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.5 |
1.5 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.5 |
3.0 |
GO:0002679 |
respiratory burst involved in defense response(GO:0002679) |
| 0.5 |
1.5 |
GO:0051974 |
negative regulation of telomerase activity(GO:0051974) |
| 0.5 |
8.5 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.5 |
6.4 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 0.5 |
2.0 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.5 |
3.9 |
GO:0010759 |
positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.5 |
10.7 |
GO:0035774 |
positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.5 |
7.7 |
GO:0061157 |
mRNA destabilization(GO:0061157) |
| 0.5 |
3.3 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.5 |
1.4 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 0.5 |
3.8 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.5 |
1.4 |
GO:1903599 |
positive regulation of mitophagy(GO:1903599) |
| 0.5 |
6.6 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.5 |
1.4 |
GO:0000710 |
meiotic mismatch repair(GO:0000710) |
| 0.5 |
7.5 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.5 |
4.6 |
GO:0071371 |
cellular response to gonadotropin stimulus(GO:0071371) |
| 0.5 |
6.9 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.5 |
1.8 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.5 |
4.1 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.5 |
5.9 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.5 |
0.9 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.4 |
6.3 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.4 |
4.0 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.4 |
1.3 |
GO:0002323 |
natural killer cell activation involved in immune response(GO:0002323) |
| 0.4 |
12.8 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.4 |
4.0 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.4 |
6.6 |
GO:2000785 |
regulation of autophagosome assembly(GO:2000785) |
| 0.4 |
6.9 |
GO:0009072 |
aromatic amino acid family metabolic process(GO:0009072) |
| 0.4 |
1.3 |
GO:0060468 |
prevention of polyspermy(GO:0060468) |
| 0.4 |
49.3 |
GO:0071805 |
potassium ion transmembrane transport(GO:0071805) |
| 0.4 |
1.3 |
GO:0045629 |
positive regulation of T-helper 1 cell differentiation(GO:0045627) negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.4 |
1.3 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.4 |
6.7 |
GO:1900026 |
positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
| 0.4 |
8.3 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.4 |
1.7 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.4 |
2.0 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.4 |
4.0 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.4 |
9.3 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.4 |
2.4 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.4 |
2.0 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.4 |
2.0 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
| 0.4 |
8.0 |
GO:0071242 |
cellular response to ammonium ion(GO:0071242) acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.4 |
25.3 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.4 |
4.3 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.4 |
1.6 |
GO:0031033 |
myosin filament organization(GO:0031033) |
| 0.4 |
1.6 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.4 |
2.7 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.4 |
0.8 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 0.4 |
3.1 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.4 |
2.3 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.4 |
1.5 |
GO:0010993 |
regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.4 |
1.9 |
GO:0021592 |
fourth ventricle development(GO:0021592) initiation of neural tube closure(GO:0021993) |
| 0.4 |
1.9 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.4 |
2.3 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.4 |
1.5 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.4 |
1.1 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.4 |
1.5 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.4 |
4.1 |
GO:1900746 |
regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
| 0.4 |
7.8 |
GO:0000045 |
autophagosome assembly(GO:0000045) |
| 0.4 |
1.5 |
GO:0072176 |
nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
| 0.4 |
1.5 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.4 |
1.5 |
GO:0072578 |
neurotransmitter-gated ion channel clustering(GO:0072578) |
| 0.4 |
6.9 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.4 |
6.8 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.4 |
3.2 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.4 |
1.1 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.4 |
1.1 |
GO:0019042 |
viral latency(GO:0019042) |
| 0.4 |
1.1 |
GO:0051031 |
tRNA transport(GO:0051031) |
| 0.3 |
1.7 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.3 |
2.4 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.3 |
8.6 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.3 |
4.1 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.3 |
1.0 |
GO:0009597 |
detection of virus(GO:0009597) |
| 0.3 |
1.0 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 0.3 |
4.0 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.3 |
0.3 |
GO:0090148 |
membrane fission(GO:0090148) |
| 0.3 |
0.7 |
GO:2000078 |
columnar/cuboidal epithelial cell maturation(GO:0002069) positive regulation of type B pancreatic cell development(GO:2000078) |
| 0.3 |
1.3 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.3 |
2.6 |
GO:0097341 |
inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.3 |
0.3 |
GO:0071072 |
negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.3 |
2.6 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.3 |
2.6 |
GO:0097576 |
autophagosome maturation(GO:0097352) vacuole fusion(GO:0097576) |
| 0.3 |
2.6 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.3 |
4.4 |
GO:2001258 |
negative regulation of cation channel activity(GO:2001258) |
| 0.3 |
1.3 |
GO:0015871 |
choline transport(GO:0015871) negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.3 |
2.2 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.3 |
1.5 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.3 |
3.9 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.3 |
7.6 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 0.3 |
0.6 |
GO:1902995 |
negative regulation of beta-amyloid formation(GO:1902430) regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
| 0.3 |
2.3 |
GO:0032261 |
purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
| 0.3 |
0.6 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.3 |
2.0 |
GO:0051560 |
mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.3 |
0.9 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 0.3 |
2.8 |
GO:0002098 |
tRNA wobble uridine modification(GO:0002098) |
| 0.3 |
0.8 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.3 |
12.5 |
GO:0035904 |
aorta development(GO:0035904) |
| 0.3 |
6.9 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.3 |
5.8 |
GO:0072384 |
organelle transport along microtubule(GO:0072384) |
| 0.3 |
4.3 |
GO:0043045 |
DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 0.3 |
0.5 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.3 |
0.8 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.3 |
1.1 |
GO:0052490 |
suppression by virus of host apoptotic process(GO:0019050) negative regulation by symbiont of host apoptotic process(GO:0033668) modulation by virus of host apoptotic process(GO:0039526) response to cycloheximide(GO:0046898) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
| 0.3 |
0.8 |
GO:0016056 |
rhodopsin mediated signaling pathway(GO:0016056) |
| 0.3 |
6.8 |
GO:1900078 |
positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.3 |
4.2 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.3 |
0.8 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.3 |
3.1 |
GO:0032967 |
positive regulation of collagen biosynthetic process(GO:0032967) |
| 0.3 |
1.3 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.3 |
0.5 |
GO:0090289 |
regulation of osteoclast proliferation(GO:0090289) |
| 0.3 |
0.8 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.2 |
0.7 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.2 |
5.2 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.2 |
1.7 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.2 |
4.4 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.2 |
0.5 |
GO:0060149 |
negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
| 0.2 |
1.0 |
GO:0072362 |
regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072362) |
| 0.2 |
1.4 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.2 |
3.3 |
GO:0048635 |
negative regulation of muscle organ development(GO:0048635) |
| 0.2 |
0.9 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.2 |
10.7 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.2 |
6.8 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.2 |
1.8 |
GO:0033572 |
transferrin transport(GO:0033572) |
| 0.2 |
0.9 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.2 |
1.3 |
GO:0072319 |
vesicle uncoating(GO:0072319) |
| 0.2 |
0.6 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) general adaptation syndrome(GO:0051866) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.2 |
2.6 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.2 |
1.1 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.2 |
1.9 |
GO:0036159 |
inner dynein arm assembly(GO:0036159) |
| 0.2 |
0.4 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.2 |
12.8 |
GO:0099643 |
neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
| 0.2 |
0.6 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.2 |
0.4 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.2 |
1.2 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.2 |
0.4 |
GO:0050651 |
dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.2 |
1.6 |
GO:0042506 |
tyrosine phosphorylation of Stat5 protein(GO:0042506) |
| 0.2 |
6.5 |
GO:0050729 |
positive regulation of inflammatory response(GO:0050729) |
| 0.2 |
2.2 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.2 |
0.8 |
GO:0090399 |
replicative senescence(GO:0090399) |
| 0.2 |
2.4 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.2 |
17.4 |
GO:0035023 |
regulation of Rho protein signal transduction(GO:0035023) |
| 0.2 |
6.9 |
GO:0033014 |
porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
| 0.2 |
1.9 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.2 |
1.5 |
GO:2001214 |
positive regulation of vasculogenesis(GO:2001214) |
| 0.2 |
5.2 |
GO:0050775 |
positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.2 |
1.7 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.2 |
0.9 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.2 |
0.2 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.2 |
17.4 |
GO:0098792 |
xenophagy(GO:0098792) |
| 0.2 |
7.8 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
| 0.2 |
2.6 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.2 |
1.5 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.2 |
4.3 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.2 |
1.3 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.2 |
0.5 |
GO:0016239 |
positive regulation of macroautophagy(GO:0016239) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
| 0.2 |
1.3 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.2 |
0.3 |
GO:0007603 |
phototransduction, visible light(GO:0007603) |
| 0.2 |
2.6 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.2 |
2.6 |
GO:0007193 |
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.2 |
3.9 |
GO:0006513 |
protein monoubiquitination(GO:0006513) |
| 0.2 |
0.6 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.2 |
0.6 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.2 |
0.3 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.2 |
2.1 |
GO:0044243 |
collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
| 0.1 |
0.3 |
GO:0071455 |
cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
| 0.1 |
2.5 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.1 |
1.5 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.1 |
2.2 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.1 |
0.9 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.1 |
1.7 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 |
3.7 |
GO:0050919 |
negative chemotaxis(GO:0050919) |
| 0.1 |
16.5 |
GO:0007018 |
microtubule-based movement(GO:0007018) |
| 0.1 |
0.4 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.1 |
0.8 |
GO:0032328 |
alanine transport(GO:0032328) |
| 0.1 |
2.4 |
GO:0050806 |
positive regulation of synaptic transmission(GO:0050806) |
| 0.1 |
3.8 |
GO:0051647 |
nucleus localization(GO:0051647) |
| 0.1 |
0.7 |
GO:0006591 |
ornithine metabolic process(GO:0006591) |
| 0.1 |
1.8 |
GO:0036065 |
fucosylation(GO:0036065) |
| 0.1 |
1.1 |
GO:0090042 |
tubulin deacetylation(GO:0090042) |
| 0.1 |
0.3 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.1 |
0.4 |
GO:1902605 |
heterotrimeric G-protein complex assembly(GO:1902605) |
| 0.1 |
0.3 |
GO:0072053 |
establishment of endothelial blood-brain barrier(GO:0014045) central nervous system vasculogenesis(GO:0022009) renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 0.1 |
2.5 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.1 |
1.4 |
GO:0000059 |
protein import into nucleus, docking(GO:0000059) |
| 0.1 |
5.2 |
GO:0014065 |
phosphatidylinositol 3-kinase signaling(GO:0014065) |
| 0.1 |
0.5 |
GO:0046851 |
negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
| 0.1 |
14.8 |
GO:0043087 |
regulation of GTPase activity(GO:0043087) |
| 0.1 |
3.6 |
GO:0006829 |
zinc II ion transport(GO:0006829) |
| 0.1 |
1.4 |
GO:0042659 |
regulation of cell fate specification(GO:0042659) |
| 0.1 |
1.3 |
GO:0014898 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 |
4.1 |
GO:0010811 |
positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.1 |
0.5 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.1 |
0.6 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.1 |
1.7 |
GO:0072348 |
sulfur compound transport(GO:0072348) |
| 0.1 |
0.5 |
GO:0006882 |
cellular zinc ion homeostasis(GO:0006882) zinc ion homeostasis(GO:0055069) |
| 0.1 |
2.6 |
GO:0051220 |
cytoplasmic sequestering of protein(GO:0051220) |
| 0.1 |
0.2 |
GO:0060177 |
regulation of angiotensin metabolic process(GO:0060177) |
| 0.1 |
1.2 |
GO:0010960 |
magnesium ion homeostasis(GO:0010960) |
| 0.1 |
1.1 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.1 |
1.8 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.1 |
1.3 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.1 |
0.5 |
GO:0060633 |
negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
| 0.1 |
0.4 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.1 |
1.1 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.1 |
0.7 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.1 |
0.5 |
GO:2001239 |
regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
| 0.1 |
0.3 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.1 |
5.6 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.1 |
1.1 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.1 |
0.4 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 |
1.6 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 |
0.8 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.1 |
0.3 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.1 |
0.7 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
| 0.1 |
1.7 |
GO:0051569 |
regulation of histone H3-K4 methylation(GO:0051569) |
| 0.1 |
0.7 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 |
1.9 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.1 |
0.3 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.1 |
0.4 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
| 0.1 |
0.2 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 |
0.6 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.1 |
0.3 |
GO:0046689 |
response to mercury ion(GO:0046689) |
| 0.1 |
0.5 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.1 |
4.7 |
GO:0043433 |
negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
| 0.1 |
1.1 |
GO:0006541 |
glutamine metabolic process(GO:0006541) |
| 0.1 |
0.6 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.1 |
0.4 |
GO:2000811 |
negative regulation of anoikis(GO:2000811) |
| 0.1 |
1.4 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.1 |
0.8 |
GO:0034088 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.1 |
0.1 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.1 |
0.4 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.1 |
0.4 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.1 |
0.8 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
| 0.1 |
0.3 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 |
0.4 |
GO:0097186 |
amelogenesis(GO:0097186) |
| 0.1 |
0.2 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.1 |
7.0 |
GO:0050890 |
cognition(GO:0050890) |
| 0.1 |
6.6 |
GO:0002244 |
hematopoietic progenitor cell differentiation(GO:0002244) |
| 0.1 |
1.2 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.1 |
0.5 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.1 |
1.5 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.1 |
2.1 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.1 |
1.0 |
GO:1903146 |
regulation of mitophagy(GO:1903146) |
| 0.0 |
0.9 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.0 |
0.0 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.0 |
0.3 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.0 |
0.4 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.0 |
0.8 |
GO:0018279 |
protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.0 |
0.1 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.0 |
0.5 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.0 |
1.5 |
GO:0043631 |
mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
| 0.0 |
0.4 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.0 |
0.8 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 |
0.5 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.0 |
0.4 |
GO:0006836 |
neurotransmitter transport(GO:0006836) |
| 0.0 |
0.2 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.0 |
0.5 |
GO:0010595 |
positive regulation of endothelial cell migration(GO:0010595) |
| 0.0 |
0.1 |
GO:0033866 |
nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.0 |
0.2 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.0 |
0.3 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 |
0.7 |
GO:0032755 |
positive regulation of interleukin-6 production(GO:0032755) |
| 0.0 |
0.2 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.0 |
0.2 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.0 |
0.1 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.0 |
0.1 |
GO:0061462 |
protein localization to lysosome(GO:0061462) |
| 0.0 |
0.2 |
GO:0043687 |
post-translational protein modification(GO:0043687) |
| 0.0 |
1.1 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.0 |
0.2 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.0 |
0.1 |
GO:0060044 |
negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.0 |
0.0 |
GO:0042346 |
positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.0 |
0.4 |
GO:0048813 |
dendrite morphogenesis(GO:0048813) |
